Starling Oncology, Inc. Shares Issued
Starling Oncology, Inc. (STLN) had Shares Issued of 102.20 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 102.20M shares.
- 2026-03-31: Common Stock, Shares, Issued 101.71M shares.
- 2025-12-31: Common Stock, Shares, Issued 100.60M shares.
- 2025-09-30: Common Stock, Shares, Issued 99.30M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 102.20M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 101.71M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 100.60M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 99.30M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 95.01M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 90.66M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 77.47M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 77.29M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 77.22M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 76.05M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 75.88M shares 10-K · filed 2025-03-26 |
| 2023-09-30 | 75.46M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 74.55M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 73.75M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 73.27M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 72.34M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 71.98M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 73.28M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 73.25M shares 10-K · filed 2023-03-16 |
| 2021-09-30 | 23.00M shares 10-Q/A · filed 2021-12-14 |
| 2021-06-30 | 23.00M shares 10-Q · filed 2021-08-16 |
| 2021-03-31 | 23.00M shares 10-Q · filed 2021-05-28 |
| 2020-12-31 | 23.00M shares 10-Q/A · filed 2021-12-14 |